Posted on March 17th, 2010 by
A simple genetic test can reduce hospitalization rates by almost a third for heart patients taking warfarin, the world's most-prescribed blood thinner, according to a study released today by researchers from Medco Health Solutions, Inc. (in association with the Medco Research Institute) and the Mayo Clinic…
"The test provides the information a physician needs to more precisely dose a patient so that an individual who has a low sensitivity to the drug can be dosed higher to minimize the risk of stroke and someone who is highly sensitive to the drug can be given a lower dose to avoid bleeding," said Thomas P. Moyer at Mayo Clinic's Department of Laboratory Medicine and Pathology and co-author of the study.
Healthcare IT News, by Mike Milliard, 3/15/2010
You must be logged-in to the site to post a comment.